FDMT
USD4D Molecular Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$11.020
High
$11.020
Low
$10.040
Volume
0.63M
Company Fundamentals
Market Cap
578.4M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.80M
Exchange
NMS
Currency
USD
52-Week Range
Related News
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific
4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for development activities supporting global registration Up to $336
RBC Capital Reiterates Outperform on 4D Molecular Therapeutics, Maintains $26 Price Target
RBC Capital analyst Lisa Walter reiterates 4D Molecular Therapeutics with a Outperform and maintains $26 price target.
4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
EMERYVILLE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (NASDAQ:FDMT, 4DMT or the Company)), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.